Exchange Announcement • 04 Jun 2026 04:07
Exchange Announcement • 04 Jun 2026 04:06
Exchange Announcement • 03 Jun 2026 18:02
Exchange Announcement • 23 May 2026 04:50
Exchange Announcement • 07 May 2026 05:15
𝛼SK or SearchENTITY
Mineralys Therapeutics (MLYS US)
Mineralys Therapeutics (MLYS US)
1
Analysis
Health Care • United States
Mineralys Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Mineralys Therapeutics offers aldosterone synthase inhibitor (ASI) that we are initially developing for the treatment of patients with uncontrolled hypertension.
morex